Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Company Information
About this company
Key people
Stuart M. Essig
Chairman of the Board, President, Chief Executive Officer
Barbara B. Hill
Independent Presiding Director
Keith Bradley
Independent Director
Shaundra D. Clay
Independent Director
Jeffrey A. Graves
Independent Director
Renee W. Lo
Independent Director
Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chantal Veillon
Chief Human Resources Officer, Executive Vice President
Michael Damon Hutchinson
Executive Vice President, Chief Legal Officer, Secretary
Robert T. Davis
Executive Vice President, President - Tissue Technologies
Harvinder Singh
Executive Vice President, President - International Business
Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Teshtar Elavia
Corporate Vice President, Chief Technology Officer
Michael J. McBreen
Chief Commercial Officer
Click to see more
Key facts
- Shares in issue92.15m
- EPICIART
- ISINUS4579852082
- LocationUnited States
- SectorTechnology
- IndustryScientific & Technical Instr.
- Market cap$1.09bn
- Employees4,427
- ExchangeNASDAQ
- IndexS&P 600 Small Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.